[ 會員#25873 ] karry tse
化療一年後PET SCAN跟進
醫生你好。母親65歲，2019年10月確診三陰性乳癌，12月切除右邊腋下淋巴及全個右邊乳房。2020年2月起開始化療至5月底中斷（打了四針紅針及一針紫杉醇，5月底因感染入ICU後醫生指不適宜繼續化療。其後在8月-9月電療。之後持續跟進。
以下為剛於2022年6月做的PET SCAN報告，請問有否異常？謝謝﹗
Procedure: WB Breast Ca FDG
Pharmaceutica l: F18-fluorodeoxyglucose 11.91 mCi
Clinical information (from referring clinician):
triple negative breast cancer in remission. PE ICT done as FU. last PET in 11/2020 noted mildly
hpermetabolic GGO at anterior Rt lung ? post RT changes
Diagnosis (from referring clinician):
ca breast
Report:
F18-FDG ONCOLOGY PETICT SCAN REPORT
PROCEDURE
Patient fasting
F18-FDG was then injected intravenously.
PET imaging from head to upper thigh was taken after 60 minutes.
Plain CT for attenuation correction and localization.
PET/CT FINDINGS
Blood glucose level 5.5 mmol/l at the time of FDG injection.
Comparison with prior study dated 25-11-2020.
No gross hypermetabolic brain mass. The ventricles are not dilated. No midline shift.
(Please note that FDG PET is not sensitive in detecting small brain lesions.)
NP, tonsils, para-nasal sinuses and larynx are unremarkable.
Hypermetabolic left upper jugular node (SUVmax 7.5, 5mm) can represent reactive
lymphadenopathy, less likely DDx metastatic node.
No hypermetabolic enlarged SCF node.
Status post right modified radical mastectomy with mild FDG activity over right anterior chest wall
and axilla probably due to post-treatment changes.
No gross FDG-avid left breast mass seen.
Similar small left axillary nodes with mild FDG activity (6mm, SUVmax 1.7), likely reactive in nature.
Concerned mildly hypermetabolic streaky opacity at right lung apex is stable in appearance and
uptake (ım92, 18mm, SUVmax 1.7; previous 20mm, SUVmax 2.1).
Mildly hypermetabolic ground glass opacities at sudpleural anterior right lung are seen, likely due to
post-RT changes
Mild bronchiectasis over medial RML noted.
No enlarged hypermetabolic mediastinal lymphadenopathy.
No pleura or pericardial effusion.
No hypermetabolic mass over adrenals, liver, spleen, pancreas and kidneys.
Gallstone noted.
No enlarged hypermetabolic lymphadenopathy seen in abdomen and pelvis.
The bowel uptake is unremarkable.
No abnormal FDG focus over uterus.
No ascites.
No hypermetabolic bone secondary is seen within the scanning range.
A small mildly FDG avid subcutaneous nodule at left proximal arm (SUVmax 1.6, 2mm, Im 69) is
non-specific, may represent inflammatory nodule.
(Lymph nodes are measured in short axis.)
IMPRESSION:
1. Status post right modified radical mastectomy. No gross hypermetabolic right chest wall mass to
suggest local recurrence.
2. Concerned streaky opacity at right lung apex with non-specific mild FDG activity is stable in
morphological appearance and FDG uptake
3. Hypermetabolic left upper jugular node can represent reactive lymphadenopathy, less likely DDx
metastatic node.
以下為剛於2022年6月做的PET SCAN報告，請問有否異常？謝謝﹗
Procedure: WB Breast Ca FDG
Pharmaceutica l: F18-fluorodeoxyglucose 11.91 mCi
Clinical information (from referring clinician):
triple negative breast cancer in remission. PE ICT done as FU. last PET in 11/2020 noted mildly
hpermetabolic GGO at anterior Rt lung ? post RT changes
Diagnosis (from referring clinician):
ca breast
Report:
F18-FDG ONCOLOGY PETICT SCAN REPORT
PROCEDURE
Patient fasting
F18-FDG was then injected intravenously.
PET imaging from head to upper thigh was taken after 60 minutes.
Plain CT for attenuation correction and localization.
PET/CT FINDINGS
Blood glucose level 5.5 mmol/l at the time of FDG injection.
Comparison with prior study dated 25-11-2020.
No gross hypermetabolic brain mass. The ventricles are not dilated. No midline shift.
(Please note that FDG PET is not sensitive in detecting small brain lesions.)
NP, tonsils, para-nasal sinuses and larynx are unremarkable.
Hypermetabolic left upper jugular node (SUVmax 7.5, 5mm) can represent reactive
lymphadenopathy, less likely DDx metastatic node.
No hypermetabolic enlarged SCF node.
Status post right modified radical mastectomy with mild FDG activity over right anterior chest wall
and axilla probably due to post-treatment changes.
No gross FDG-avid left breast mass seen.
Similar small left axillary nodes with mild FDG activity (6mm, SUVmax 1.7), likely reactive in nature.
Concerned mildly hypermetabolic streaky opacity at right lung apex is stable in appearance and
uptake (ım92, 18mm, SUVmax 1.7; previous 20mm, SUVmax 2.1).
Mildly hypermetabolic ground glass opacities at sudpleural anterior right lung are seen, likely due to
post-RT changes
Mild bronchiectasis over medial RML noted.
No enlarged hypermetabolic mediastinal lymphadenopathy.
No pleura or pericardial effusion.
No hypermetabolic mass over adrenals, liver, spleen, pancreas and kidneys.
Gallstone noted.
No enlarged hypermetabolic lymphadenopathy seen in abdomen and pelvis.
The bowel uptake is unremarkable.
No abnormal FDG focus over uterus.
No ascites.
No hypermetabolic bone secondary is seen within the scanning range.
A small mildly FDG avid subcutaneous nodule at left proximal arm (SUVmax 1.6, 2mm, Im 69) is
non-specific, may represent inflammatory nodule.
(Lymph nodes are measured in short axis.)
IMPRESSION:
1. Status post right modified radical mastectomy. No gross hypermetabolic right chest wall mass to
suggest local recurrence.
2. Concerned streaky opacity at right lung apex with non-specific mild FDG activity is stable in
morphological appearance and FDG uptake
3. Hypermetabolic left upper jugular node can represent reactive lymphadenopathy, less likely DDx
metastatic node.
潘智文醫生回覆:
14/06/2021
14/06/2021
單憑正電子掃描報告來判斷，並沒又復發的跡象，但這不能作準，因為醫生一定要同步看影像才能作最終的建議
以上資料只供參考，不能作診症用途，
請與家庭醫生查詢並作出適合治療。
如有身體不適請即求診，切勿延誤治療。
若資料有所漏誤，本網及相關資料提供者恕不負責。
請與家庭醫生查詢並作出適合治療。
如有身體不適請即求診，切勿延誤治療。
若資料有所漏誤，本網及相關資料提供者恕不負責。
Eric Leung : 局部麻醉神經阻斷
我媽媽的脊骨有惡性腫瘤(L4 & L5 的位置), 過去幾年已透過電療, 化療, 及兩次手術等不同方式去治療,.......Kilmer : 肺癌患者
請問肺癌患者失眠吃失眠藥有那些藥合用呢？.......Vilia : 胸腺瘤開胸手術六年後复发
病患者男 - 41歲 AB型胸腺瘤開胸手術六年後复发，增强CT示前上纵隔气管左前方见一卵圆形软组织密度结.......Debby : 霍奇金淋巴瘤
病患者男 - 53歲 醫生，你好。我想問一下我的叔叔得了霍奇金淋巴瘤，之後在上海醫院進行骨髓移植，手術是.......WONG WAI YAN : 胰臟癌末期免疫治療有效嗎？
病患者女 - 68歲 我媽媽半年前確診胰臟癌三期，8月份做完一round 電療化療後腫瘤縮小了，癌指數也.......Michelle : 切除大髀內側腫瘤
病患者女 - 60歲 剛做完大脾內側切除脂肪瘤手術，發覺有腫脹是否正常？還有什麼後遺症？.......kit : 肝癌擴散到肺
病患者男 - 37歲 在國內判斷為肝癌末期，擴散到肺！那麼我可以找那方面的專家 ....... 發出提問使用細則
致潘智文醫生 提問
